Industrias Peñoles

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Volodymyr Zelenskyy’s first official visit to Serbia is deepening Kyiv-Belgrade trade and political ties even as Serbia maintains energy links with Russia. Representative image.

Ukraine offers reciprocal Black Sea and energy truce as Zelenskyy puts decision on Russia

Roche’s experimental once-weekly obesity and diabetes drug enicepatide delivered 15.5% average weight loss and strong HbA1c reductions in a Phase II trial, strengthening its challenge in the fast-growing weight-loss drug market. Representative image.

Roche’s enicepatide delivers 15.5% weight loss in type 2 diabetes Phase II trial

Mercedes-Benz signs production deal for Wayve AI Driver launch within two years

Iran and US open diplomatic channel as Pezeshkian links Hormuz reopening to end of pressure

Representative image of a large precious metals mining operation, illustrating the Fresnillo plc share price surge as investors weigh whether the FTSE 100 miner’s 2026 guidance cut is a temporary pause in the silver and gold bull run.

Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?

Fresnillo (LSE: FRES) posted record $2.80bn EBITDA in 2025 but trimmed 2026 silver and gold guidance. Retail investor roadmap to the stock's next catalyst.

μFR system
αvβ6-integrin
α4β7 integrin
Þorgerður Katrín Gunnarsdóttir
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF

April 18, 2026